VRC 016

VRC 016 A Phase 1b Open-Label, Randomized Clinical Trial to Evaluate Early Innate and Adaptive Immune Responses to the Investigational HIV-1 Vaccines: VRC-HIVADV014-00-VP and VRC-HIVDNA016-00-VP in Ad5 Seronegative Healthy Adults

Trial Details:

Ib Completed
National Institute of Allergy and Infectious Diseases (NIAID) June 01, 2011
VRC-HIVADV014-00-VP,VRC-HIVDNA016-00-VP DNA env A, env b, env C, gag B, pol B, nef B; Ad5 env A, env B, env C, gag B, pol B
VRC-HIVADV014-00-VP Viral Vector - Adeno
USA 36